IMMUNIZATION WITH ENCEPHALOMYELITIS VIRUS.
I the immunization of guinea pigs and horses with pigeon-modified, equine encephalomyelitis virus (7) . Source of Virus.--The Eastern and Western strains, ultimately derived from affected horses and propagated in guinea pigs, were transferred to the brain of mice. The virus was passed serially in this way from mouse to mouse until the 40th, or a still further passage when modification of the virus was revealed by its diminished pathogenicity after injection in the subcutis of guinea pigs. This was not true as concerns injections into the brain. To illustrate, the same quantity of mouse brain virus as before (0.03 cc.) was lethal intracerebrally in mice and guinea pigs in dilutions of 10 -4 to 10 -~ inclnsive. It was now, however, not diseaseproducing when 1 cc. of these dilutions was injected subcutaneously in guinea pigs. By contrast, guinea pig brain virus, before mouse passage, was active in guinea pigs when given subcutaneously, regularly in dilutions up to 10 -a and occasionally up to 10 -7 (see Tables I, II , and III which summarize the results of such titrations and are examples of repeated observations).
Preparation of Material.--For use as antigen the brains of mice which succumbed to mouse passage virus were removed aseptically and ground to a 10 per cent sus- At right of double line is shown a simultaneous titration of virus by intracerebral inoculation of mice; the numerator represents number of mice that died of the experimental disease; the denominator, the number of animals employed in the test. pension in broth. The suspension was spun in an angle centrifuge at 3,000 R.P.K. for ! 5 minutes and the required dilutions were prepared from the supernatant fluid.
This constituted fresh material, but it was often desired to inject an~m~1.~ with known quantities of virus and to repeat the injection at weekly intervals; hence the material had to be maintained in undiminished concentration. Two methods of preservation were employed: merthiolate and desiccation. Of the two, the latter was preferable since the virus content did not diminish as rapidly over long periods of time.
A 2 per cent suspension of infected mouse brains in Tyrode's solution, pH 7.6, containing merthiolate 1:5,000 was made. The suspension was filtered through 8 ply sterile gauze, diluted with three volumes of sterile, distilled water, and stored in the cold. The material, which contained 300,000 mouse infective units (hereafter called m.i.u.) ~ per cc. immediately after its preparation, was found after storage for 4½ months to contain 3,000 m.i.u, per cc. of virus. Desiccated material was obtained as follows: Mouse brains removed from animals before death were ground to a l0 per cent suspension in Tyrode's solution, pH 7.6, or in l0 per cent normal rabbit serum diluted with Tyrode's solution. After centrifugation at 4,000 R.P.~. in an angle machine for 20 minutes, the superuatant fluid was removed and tubed in 1½ cc. quantities and dried in va~uo in the cold over sulfuric acid. Dried virus, after storage for 12 weeks, still contained the original amount of the active agent (usually 3 X l05 to 3 X l0 s m.i.u, per cc. of resuspended material). The effect of longer storage on dried virus has still to be determined.
The two strains, Eastern and Western, prepared separately or mixed in the same specimen, exhibited no noticeable difference in immunizing power.
Dosage.--All virus samples were titrated before use by mouse intracerebral inoculation. In this way the number of m.i.u, of virus was determined. For preventive inoculation of guinea pigs 1 cc. was injected subcutaneously and, when indicated, repeated at 7 to 13 day intervals. Control guinea pigs and mice were included in each experiment to measure the activity of varying dilutions of virus by means of inoculation intracerebraUy, or subcutaneously, or by instillation intranasally (see Tables I to III Test for Resistance.--Although guinea pigs were immunized with mouse passage virus, they received as test dose for induced resistance guinea pig brain passage virus, as did all animals throughout this study.
An intracerebral test was found to be more drastic than an intranasal or a subcutaneous one. To illustrate, guinea pigs received subduraUy 0.12 cc., subcutaneously, 1 cc., or intranasaUy, 0.1 cc. of virus suspension. With the volumes used, normal guinea pigs reacted with characteristic lethal encephalitis in limiting dilutions of 10 -6 or even 10 -7 after intracerebral inoculation; and the same happened with 10 -3 on subcutaneous injection, and with dilutions of 1:100 to 1:200 after intranasal instillation. Therefore, to determine induced resistance, 103 to 104 M.L.D. were introduced into the brain, whereas in the skin or nose, lightly centrifuged, 10 per cent fresh virus suspension was employed, representing 1 to 10 U.LD.
Effect of Storage.--The virus employed as immunizing agent was still effective after it had been stored in the cold for 3 months, at least. Immunization with Mouse Passage Virus.--We first sought to find the minimal amounts and number of doses necessary for active immunization against the intracerebral test dose. Table IV summarizes the experiments. Reference to the table shows that lessened resistance occurred in animals treated with amounts of virus smaller than 3 X 10 8 m.i.u., and even with this amount if it was given less than three times.
Larger quantities, i.e., more than 3 X 10 4 m.i.u., injected less than three times, were also effective in developing immunity but the danger then arose of increasing correspondingly the incidence of fever, circu-lating virus,* and death during the period of immunization. In other words, it was essential that the preventive dose should confer protection with the use of the least possible amount of virus, thus minimizing febrile reactions and blood infection. This dose has been determined as 3 X 108 to 3 × 104 m.i.u, injected subcutaneously three times at weekly intervals. It will be noted that absence of fever during the period of immunization does not necessarily foretell a diminution in the degree of induced protection.
Immunization against Nasal and Subcutaneous Infection.--The next series of experiments (Table V) reveals that protection against nasal and subcutaneous test injections can be secured by means of one or two subcutaneous injections, each containing 3 X 10 4 m.i.u, of virus.
At this point, the fact should be mentioned that normal mice and guinea pigs receiving virus nasally and resisting infection may be susceptible to a later nasal instillation. Again, animals injected subcutaneously once or twice with smaller amounts of active virus are refractory to the nasal test but may succumb to the disease after a later intracerebral inoculation. Apparently intranasal application of virus fails to increase the degree of resistance. This is in striking agreement with the results obtained by Jungeblut and Hazen (8) and by Flexner (9) in studies on experimental poliomyelitis in the monkey. As stated by Flexner, refractory monkeys which resist not only one but several courses of nasal instillations of poliomyelitis virus develop no indication of either active or passive immunity.
In summing up the series in which untreated mouse passage virus was used as immunizing agent, it appears that a sufficient amount of the material and its periodic inoculation are required to produce effective protection. The sufficient amount has been measured as 3 X 10 3 to 3 X 10 4 m.i.u.: one or two such doses given subcutaneously protect * The usual procedure for detecting circulating virus is limited in application, since 0.03 cc. of blood derived from an affected guinea pig, usually during the height of fever, or from the 2nd to 5th day after the primary injection, is introduced into the brain of each of four or six mice for the specimen to be examined. While positive reactions are unequivocal, negative ones are less significant for only a small amount of blood is put to test. However, these tests were made with the purpose of comparing the results obtained in each series of animals treated with active virus. guinea pigs against experimental subcutaneous or intranasal infection and three doses, given at weekly intervals, against intracerebral test inoculation of 103 to 104 lethal units. Further, fever occurred in only eleven of 126 animals given this dosage, and in only one instance was Table I ; of thirty control guinea pigs used, twenty-seven died of characteristic encephalitis after nasal or subcutaneous injection of the test dose.
t These six guinea pigs withstood an intranasal test 16 days after the last preventive dose was inoculated but one of them died after all had received a second intranasal test 4 days later. the febrile reaction accompanied by the presence of virus in the blood as determined by our method. The incidence of fever and of blood infection increases in those animals receiving larger amounts of virus--quantities in excess of what is needed for building up resistance. Mter storing,--the longest period thus far being 3 months,--the im-munizing agent still contained an adequate amount of virus for the production of uniform resistance to the usual intracerebral test. Finally, the protection acquired is durable, lasting throughout at least 3 months.
Adsorbed Virus as Immunizing Preparation
Aluminum hydroxide, Type C, first employed by Willstaetter (10) to purify enzymes, was chosen as the agent for adsorption (11) . It was shown in a preliminary report (12) that the material adsorbed the encephalomyelitis virus and then could induce active protection in guinea pigs. The subject has since been more extensively elaborated and the results of this work are now presented.
Mouse rather than guinea pig passage virus was used in preparing vaccines for guinea pigs. It has already been pointed out (see also Tables II and III) that the mouse passage virus consistently displays a lesser degree of infectivity following subcutaneous injection of guinea pigs. In general, the methods employed with adsorbed virus were the same as those described in the foregoing section.
Preparation of Adsorbed Virus.--The brains of three mice which succumbed to experimental encephalomyelitis were ground in ~t/50 phosphate buffer, pH 6.6, to a 10 per cent suspension. This was centrifuged at 1500 mp.~t, for 25 minutes. To 2 cc. of the supernatant fluid were added 98 cc. of the Gel C (about 2 mg. A1203 per cc. of buffer). The mixture, which then consisted of active tissue in a dilution, by weight, of 1 : 500, was vigorously shaken and kept in the cold for 24 hours. It was next centrifuged and the deposit washed three times with 150 cc. of the buffer each time. Emphasis was laid on thorough washing, since insufficient cleansing might not have removed the excess, or unadsorbed, virus. The precipitate was resuspended in 200 cc. of Tyrode solution, pH 7; thereupon the suspension contained A12Os in a concentration of 1 rag. per ec.
When tissue cultures were used as antigens, 16.5 cc. of each cultured strain, after centrifuging to remove most of the cells, were added to 8.25 cc. of the gel (7.5 nag. per cc. of buffer). The mixture was thoroughly shaken and kept cold overnight. The alumina was sedimented by centrifugation and the deposit was washed thrice in 100 cc. of the buffer. It was then suspended in 80 cc. of Tyrode's solution pH 7; thus the concentration of A1,Oa remained approximately 0.75 rag. per co.
When both final products were titrated by means of the mouse intracerebral tests, they were found to contain 3 × l0 s to 3 × 10 4 m.i.u, of virus.
Western or Eastern strains, or both combined, differed in no way in antigenic power.
Inactivation of Virus.--A significant point is that the vaccines were not diseaseproducing as they were ordinarily employed; yet, when they were inoculated in the brain of mice and guinea pigs, or in the subcutis of guinea pigs in larger doses, characteristic lethal encephalitis ensued. Moreover, active virus was recovered from the cutaneous nodules produced by injection of alumina material. Clearly then, the adsorption process as carried out did not inactivate the infective agent.
The Local Reaction.--The local reaction that developed at the site of injection was referable to the presence of the gel, for no distinction could be made between this reaction and the one induced by aluminum hydroxide alone. It is not improbable that the reaction is characteristic of the general group of insoluble chemical agents used as adsorbents. The alumina as such persisted beneath the skin for at least 3 weeks, during which time there was marked phagocytosis by polynuclear and monocytic ceils. Later the involved area showed formation of granulation tissue including giant ceUs, together with invasion by lesser numbers of the leucocytes. Gradual retrogression in size occurred thereafter until the nodule disappeared in the 5th or 6th week. In instances in which 7.5 nag. or more of A1208 were used, a late sterile abscess supervened foUowed by ulceration, discharge of contents, and finally, healing by "secondary intention."
Although the gel virus in the immunizing dose did not produce encephalitis after subcutaneous inoculation, the infective agent was recovered from nodules excised on the 2nd and 4th but not on the 7th day after injection or later. The method employed for recovering the active agent from the lesions consisted in grinding the excised nodules to a fine pulp in a minimal amount of Tyrode solution and injecting it into the brains of six mice for each sample. No attempts at elution of the virus from the gel were made.
Effect of Storage.--The adsorbed material still retained its immunizing capacity
after being stored in the cold for 2½ and 6 months--the longest periods studied-rat which time it still contained virus. This was manifested by the lethal encephalitis induced in all of five mice after its intracerebral inoculation. How much virus was present could not be told since it was not found possible to elute the infective agent from the gel. In a sample which was stored for 5 weeks, however, a content of 3 × 104 m.i.u, was noted.
Immunization with Adsorbed Virus.--Proceeding as with the chemically untreated mouse virus, we attempted to determine the minimal immunizing dose of the adsorbed material.
Since it was difficult to elute the virus and titrate its concentration precisely, we undertook an experiment in which known quantities were added to the adsorbent, Gel C, and then used for immunization (Table VI) .
One may infer that 3 × 10 4 m.i.u, of adsorbed virus in repeated doses are as adequate for immunization as like amounts of unadsorbed, mouse passage virus.
Immuni,.ation against Nasal, Subcutaneous, and Intracerebral Tests.--When a dose of 3 × 103 to 3 × 104 m.i.u, was injected subcutaneously, it was found to ira-munize guinea pigs to experimental nasal or subcutaneous infection, as shown in Table VII . For protection against the intracerebral test, three such injections were required, just as was found to be the case when unadsorbed virus was used. On the other hand, if 3 cc. of adsorbed material were given in one inoculum, instead of 1 cc. in three doses, then febrile reactions arose, accompanied by the presence of virus in the blood. For example, in one series of six guinea pigs receiving a single large inoculum, two animals died of virus infection and three of the four survivors succumbed to the usual intracerebral test (see also Table IV ). This finding is in * In the test for acquired resistance, the guinea pig brain passage virus which was employed induced lethal encephalitis in all of six guinea pigs inoculated intracerebrally with 1 : 50 to 1 : 500,000 dilutions and in all of nine mice receiving dilutions only to 1:5,000.
t Fractions defined in Table I . For the comparative observations on the capacity of one, two, and three injections to produce resistance to an intracerebral test inoculation, see similar experiments cited in Table VII. agreement with what occurs when a similar injection of unadsorbed virus is given. It is plain that safer and more effective protection follows the use of repeated, small quantities of virus.
Febrile Reactions and Circulating Virus.--Eleven of forty-six animals receiving
3 × lif t m.i.u, of virus responded with fever, and of the eleven only two had blood infection. The incidence of febrile reactions and of circulating virus became greater with larger doses just as with unadsorbed virus.
An analysis of the experiments with alumina adsorbed virus leads to the conclusion that there is little, if any, difference in the effects of the mouse passage, unadsorbed virus and of the Gel C adsorbed material respectively. A lesser rate of absorption in vivo of the adsorbed virus could not be discerned. Indeed, it was shown that the adsorption process as here employed does not inactivate the infective agent and that an adequate amount of the alumina material, that is, adequate in antigenic capacity yet within the range of least constitutional disturbances of fever and of circulating virus, is the same as with living mouse passage virus,--3 × 103 to 3 X 104 m.i.u, given three times at weekly intervals. 
Precipitated Virus as Immunizing Preparation
The type of precipitant chosen for this study was tannin (tannic acid).
Mode of Preparation.--The fresh brains obtained from six mice which died of the experimental disease were ground to an even suspension in 90 ec. of sterile distilled water and spun in an angle centrifuge at 3,000 R.P.M. for 20 minutes. To the supernatant fluid was added a sufficient amount of 2 per cent tannin to yield a final concentration of 0.2 per cent. The precipitate formed was thoroughly agitated and the material placed in the cold for 18 to 24 hours. It was then centrifuged and the deposit washed in 100 ce. of sterile saline solution, after which the precipitate was resuspended in 90 cc. of hormone broth, pH 7.6, and stored in the cold until used.
The bacteria-free suspension in the usual dosages of 1 cc. gave rise to no nodules or other visible local reaction in the skin of guinea pigs, nor was the experimental disease induced in any of more than fifty animals employed for these tests. Infec-tion arose, however, in guinea pigs and in mice after the tannin precipitated virus was introduced directly into the brain. Precipitation by tannin, like adsorption by alumina, does not, therefore, inactivate the virus.
Titration by means of guinea pig or mouse intracerebral test, of freshly prepared precipitate revealed as a rule the presence of virus in dilutions up to 10 -4, and often higher. Active virus was recovered from specimens stored in the cold as follows: after 2 months, 30,000 m.i.u., after 3 months, 3,000 m.i.u., and after 3½ months, approximately 300 m.i.u.
In the following experiments, the procedure in general followed that hitherto employed.
Immunization with Precipitated Virus.--A summary of the experimental results follows:
When less than 3 X 103 to 3 × 104 m.i.u, of such virus were injected subcutaneously, it was found that guinea pigs were not protected against experimental intracerebral infection with 103 to 104 •.L.D. A single injection of this dose sufficed, however, to protect nine of ten guinea pigs against 1 to 5 M.L.D. given intranasally 2 to 4 weeks later, and all of five animals against these doses which are ordinarily lethal when injected subcutaneously. So also, fifteen other guinea pigs acquired immunity to nose or skin infection by means of two and three immunizing doses injected at weekly intervals. For production of complete resistance to the introduction of 103 to 104 ~.L.D. into the brain, a rigorous test, three such inocula at 7 day intervals were found necessary. All of twenty animals were thus protected, as shown by their resistance to experimental infection on the 10th to the 90th day after the last immunizing dose, although of fifteen untreated animals, all succumbed to the test inoculation.
This immunizing capacity of the tannin preparation was maintained during its storage in the cold for at least 2 months, at which time the material contained at least 3 × 104 m.i.u, per cc.
During the period of immunization, nine of thirty-eight guinea pigs receiving this quantity of precipitated virus exhibited the familiar, transitory fever on the 2nd to 4th day after inoculation, but in none was this accompanied by other signs of disease. In one of twenty-five treated animals virus was found in the blood by the described method.
Active tissue precipitated by tannin serves as an immunizing agent just as does adsorbed and unadsorbed mouse material. No evidence was obtained to indicate that the infective agent in the tannin preparation was inactivated by the process of precipitation, nor any that the rate of absorption of precipitated virus, subcutaneously injected, differed from that of adsorbed or chemically untreated virus.
SUMMARY AND CONCLUSIONS
Active Eastern or Western equine encephalomyelifisvirus in three forms,--chemically untreated but simply passaged through series of mice; adsorbed on alumina Gel C, and precipitated by tannin,--yielded practically the same results when employed for the immunization of guinea pigs.
The virus is not inactivated by the process of adsorption or precipitation: guinea pigs and mice inoculated in the brain with these materials develop lethal encephalomyelitis in the same manner as when chemically untreated mouse passage virus has been used. Moreover, there is no difference in the rate of absorption in viva of the chemically treated and untreated virus preparations. Mter storage of the three immunizing preparations--the longest periods thus far studied being 2 to 3 months for mouse passage and for precipitated suspensions, and 6 months for adsorbed material--each was found to contain an amount of virus sufficient to produce immunity in animals against the usual intracerebral test inoculation. Finally, the protection afforded by the three preparations is apparently durable, as is true of many active viruses utilized in preventive treatments.
The amount of the virus necessary to confer protection may be defined as that which immunizes (a) with the least number of antigenic units and (b) with the minimum of febrile reaction and blood infection. In proportion as this amount is exceeded, the incidence of fever and of circulating virus increases and, on the other hand, as this amount is decreased, the degree of induced immunity is diminished.
We have thus shown that for this particular virus and in the guinea pig, one or two subcutaneous doses of 1 cc. of any of the different virus preparations, each containing 3 × 103 to 3 X 104 mouse infective units, bring about protection regularly against experimental infection by way of the nose or subcutis. The results are irregular when the test is made by way of the brain. By three injections, resistance is invariably obtained against as many as 103 to 104 lethal doses, given intracerebrally.
No matter in what form the virus is given, as mouse passage, or adsorbed, or precipitated material, in certain instances fever occurs and virus circulates. With the amount of virus adequate for immuni-
